Facebook
Toll-free:1-888-852-8623

All categories

  • All categories
  • Flow Cytometry Antibodies
  • ELISA Kits
  • MACS Cell Isolation
  • Antibodies and Reagents
  • Apoptosis and Cell Health Detection
  • Metabolism Assays
  • Immunoassays
  • Cell Identification Kits
  • Proteins and Peptides
  • Cell Culture
Please enter the item number/product keyword!
Keyword cannot be empty !
INSERT SYMBOLS:
  • α
  • β
  • γ
  • δ
  • ε
  • ζ
  • η
  • θ
  • κ
  • μ
  • ω
  • σ
  • τ
  • λ
  • ⅩⅢ
  • ⅩⅢ
  • ⅩⅣ
  • ⅩⅤ
  • ⅩⅦ
  • ⅩⅧ
  • UP ↑
Recombinant IL-1RA Monoclonal Antibody - 1
  • Recombinant IL-1RA Monoclonal Antibody - 1
  • Recombinant IL-1RA Monoclonal Antibody - 2
  • Recombinant IL-1RA Monoclonal Antibody - 3
  • +1
All Size Price Qty
100μL $ 380.00
- +
50μL $ 249.00
- +
Add to cart

For research use only.

Verified Samples Verified Samples in WB: HeLa, SW480, NIH/3T3
Verified Samples in IHC: Human esophagus, Mouse esophagus
Verified Samples in IF: HeLa
Dilution WB 1:1000-1:2000,  IHC 1:50-1:200,  IF 1:50-1:100
Isotype IgG, κ
Host Rabbit
Reactivity Human,  Mouse
Applications WB,  IHC,  IF
Clonality Monoclonal;Recombinant
Immunogen Recombinant human IL-1RA fragment
Abbre IL-1RA
Synonyms IL1F,  MVCD,  IL1RN,  DIRA,  ICIL-1RA,  IL-1RN,  IL-1ra,  IL-1ra3,  IL1F3,  IL1RA,  IRAP,  MVCD4,  Anakinra,  IL1 inhibitor,  Interleukin-1 receptor antagonist protein,  F630041P17Rik,  ICIL 1RA,  ICIL1RA,  IL1RN (IL1F3),  Interleukin 1 receptor antagonist,  Intracellular IL 1 receptor antagonist type II,  Intracellular interleukin 1 receptor antagonist (icIL 1ra),  MGC10430,  Type II interleukin 1 receptor antagonist
Swissprot
Calculated MW 20 kDa
Observed MW 22 kDa
The actual band is not consistent with the expectation.

Western blotting is a method for detecting a certain protein in a complex sample based on the specific binding of antigen and antibody. Different proteins can be divided into bands based on different mobility rates. The mobility is affected by many factors, which may cause the observed band size to be inconsistent with the expected size. The common factors include:

1. Post-translational modifications: For example, modifications such as glycosylation, phosphorylation, methylation, and acetylation will increase the molecular weight of the protein.

2. Splicing variants: Different expression patterns of various mRNA splicing bodies may produce proteins of different sizes.

3. Post-translational cleavage: Many proteins are first synthesized into precursor proteins and then cleaved to form active forms, such as COL1A1.

4. Relative charge: the composition of amino acids (the proportion of charged amino acids and uncharged amino acids).

5. Formation of multimers: For example, in protein dimer, strong interactions between proteins can cause the bands to be larger. However, the use of reducing conditions can usually avoid the formation of multimers.

If a protein in a sample has different modified forms at the same time, multiple bands may be detected on the membrane.

Cellular Localization Cytoplasm, Secreted
Concentration 1 mg/mL
Buffer PBS, 50% glycerol, 0.05% Proclin 300, 0.05% protein protectant.
Purification Method Protein A purified
Research Areas Immunology
Clone No. A628
Conjugation Unconjugated
Storage Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.
Shipping Ice bag
background The founding members of the interleukin-1 (IL-1) superfamily include pro-inflammatory cytokines IL-1α, IL-1β and IL-1 receptor antagonist (IL-1RA). At least six similar proteins have been recently identified, including a homolog of IL-1RA (IL1F5). IL-1a, IL-1b and IL-1RA are mainly expressed in macrophages, monocytes, and dendritic cells. IL-1RA acts as an anti-inflammatory cytokine, binding the IL-1 receptor to limit the response to inflammation. Because it plays a key role in regulating the inflammatory response, recombinant IL-1RA is a therapeutic agent used in the treatment of diseases such as rheumatoid arthritis. Alternatively, mutation of the corresponding IL-1RA gene may be associated with susceptibility to the development of specific cancers.
Other Clones

{{antibodyDetailsPage.numTotal}} Results

Other Formats

{{formatDetailsPage.numTotal}} Results

Unconjugated

  • IF:{{item.impact}}

    Journal:{{item.journal}} ({{item.year}})

    DOI:{{item.doi}}

    Reactivity:{{item.species}}

    Sample Type:{{item.organization}}

  • Q{{(FAQpage.currentPage - 1)*pageSize+index+1}}:{{item.name}}

Product Information